Fish oil supplementation in overweight/obese patients with uncontrolled asthma a randomized trial

Annals of the American Thoracic Society

Volumn 16, Issue 5, 2019, Pages 554-562

  Lang, Jason E ^a   Mougey, Edward B ^b   Hossain, Md Jobayer ^c   Livingston, Floyd ^d   Babu Balagopal, P ^b   Langdon, Scott ^a   Lima, John J ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEMOURS CHILDREN S CLINIC   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^d NEMOURS CHILDREN S HOSPITAL   (United States)

Author keywords

Asthma; EPA; Fish oil; Obesity; Omega 3 fatty acids

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; LEUKOTRIENE E4; OMEGA 3 FATTY ACID; SOYBEAN OIL; TRANSCRIPTION FACTOR SP1; FISH OIL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; BLOATING; CHILD; CLINICAL OUTCOME; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DISEASE CONTROL; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLATULENCE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GRANULOCYTE; HEADACHE; HUMAN; INTERVENTION STUDY; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTICENTER STUDY; NAUSEA; OBESE PATIENT; OBESITY; PLATELET COUNT; RANDOMIZED CONTROLLED TRIAL; RASH; RISK FACTOR; SIDE EFFECT; SINUSITIS; SORE THROAT; SPIROMETRY; TANDEM REPEAT; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINE LEVEL; XEROSTOMIA; CLINICAL TRIAL; COMPLICATION; DIETARY SUPPLEMENT; DOSE RESPONSE; FOLLOW UP; PATHOPHYSIOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ASTHMA; CHILD; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; OBESITY; OVERWEIGHT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85065017661     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201807-446OC     Document Type: Article

References (59)

1. Stream AR, Sutherland ER. Obesity and asthma disease phenotypes. Curr Opin Allergy Clin Immunol 2012;12:76–81.
2. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012;18:716–725.
3. Lang JE, Fitzpatrick AM, Mauger DT, Guilbert TW, Jackson DJ, Lemanske RF Jr, et al. National Institutes of Health/National Heart, Lung and Blood Institute AsthmaNet. Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids. J Allergy Clin Immunol 2018; 141:1459–1467, e2.
4. Lang JE, Hossain MJ, Lima JJ. Overweight children report qualitatively distinct asthma symptoms: analysis of validated symptom measures. J Allergy Clin Immunol 2015;135:886–893, e3.
5. Guilbert TW, Bacharier LB, Fitzpatrick AM. Severe asthma in children. J Allergy Clin Immunol Pract 2014;2:489–500.
6. Camargo CA Jr, Weiss ST, Zhang S, Willett WC, Speizer FE. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 1999;159:2582–2588.
7. Gold DR, Damokosh AI, Dockery DW, Berkey CS. Body-mass index as a predictor of incident asthma in a prospective cohort of children. Pediatr Pulmonol 2003;36:514–521.
8. Quinto KB, Zuraw BL, Poon KY, Chen W, Schatz M, Christiansen SC. The association of obesity and asthma severity and control in children. J Allergy Clin Immunol 2011;128:964–969.
9. Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celedón JC; Childhood Asthma Management Program Research Group. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol 2011;127:741–749.
10. Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008;178:682–687.
11. Pereira MA, Kartashov AI, Ebbeling CB, Van Horn L, Slattery ML, Jacobs DR Jr, et al. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 2005;365: 36–42.
12. Nagel G, Weinmayr G, Kleiner A, Garcia-Marcos L, Strachan DP; ISAAC Phase Two Study Group. Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood (ISAAC). Thorax 2010;65:516–522.
13. Yadav UC, Srivastava SK. Cysteinyl leukotrienes (CysLTs): role in obesity-induced asthma. Curr Mol Med 2015;15:598–605.
14. Herxheimer H, Schaefer O. Letter: asthma in Canadian Eskimos. N Engl J Med 1974;291:1419.
15. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland: incidence of some chronic diseases 1950-1974. Acta Med Scand 1980;208:401–406.
16. Bang HO, Dyerberg J, Hjøorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976;200:69–73.
17. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205–1209.
18. Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 2000;16: 861–865.
19. Hodge L, Salome CM, Hughes JM, Liu-Brennan D, Rimmer J, Allman M, et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J 1998;11:361–365.
20. Surette ME, Koumenis IL, Edens MB, Tramposch KM, Clayton B, Bowton D, et al. Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. Clin Ther 2003;25:972–979.
21. Mihrshahi S, Peat JK, Webb K, Oddy W, Marks GB, Mellis CM; CAPS Team. Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age. Pediatr Allergy Immunol 2004;15:517–522.
22. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63:116–122.
23. Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, et al. Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 1988;43:84–92.
24. Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 2006;129:39–49.
25. Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003; 168:1181–1189.
26. Romieu I, Téllez-Rojo MM, Lazo M, Manzano-Patiño A, Cortez-Lugo M, Julien P, et al. Omega-3 fatty acid prevents heart rate variability reductions associated with particulate matter. Am J Respir Crit Care Med 2005;172:1534–1540.
27. Surette ME, Koumenis IL, Edens MB, Tramposch KM, Chilton FH. Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects. Clin Ther 2003;25:948–971.
28. Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 1997;65:1011–1017.
29. Reisman J, Schachter HM, Dales RE, Tran K, Kourad K, Barnes D, et al. Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review. BMC Complement Altern Med 2006;6:26.
30. Hodge AM, Dowse GK, Gareeboo H, Tuomilehto J, Alberti KG, Zimmet PZ. Incidence, increasing prevalence, and predictors of change in obesity and fat distribution over 5 years in the rapidly developing population of Mauritius. Int J Obes Relat Metab Disord 1996;20: 137–146.
31. Marks GB, Mihrshahi S, Kemp AS, Tovey ER, Webb K, Almqvist C, et al. Prevention of asthma during the first 5 years of life: a randomized controlled trial. J Allergy Clin Immunol 2006;118:53–61.
32. Emelyanov A, Fedoseev G, Krasnoschekova O, Abulimity A, Trendeleva T, Barnes PJ. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002;20: 596–600.
33. Okamoto M, Mitsunobu F, Ashida K, Mifune T, Hosaki Y, Tsugeno H, et al. Effects of perilla seed oil supplementation on leukotriene generation by leucocytes in patients with asthma associated with lipometabolism. Int Arch Allergy Immunol 2000;122:137–142.
34. Villani F, Comazzi R, De Maria P, Galimberti M. Effect of dietary supplementation with polyunsaturated fatty acids on bronchial hyperreactivity in subjects with seasonal asthma. Respiration 1998; 65:265–269.
35. Dry J, Vincent D. Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991;95:156–157.
36. Arm JP, Horton CE, Spur BW, Mencia-Huerta JM, Lee TH. The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis 1989;139: 1395–1400.
37. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004;350:29–37.
38. Lang JE, Mougey EB, Allayee H, Blake KV, Lockey R, Gong Y, et al.; Nemours Network for Asthma Research. Nutrigenetic response to omega-3 fatty acids in obese asthmatics (NOOA): rationale and methods. Contemp Clin Trials 2013;34:326–335.
39. Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007; 120:S164–S192.
40. Juniper EF, Gruffydd-Jones K, Ward S, Svensson K. Asthma Control Questionnaire in children: validation, measurement properties, interpretation. Eur Respir J 2010;36:1410–1416.
41. Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902–907.
42. Nguyen JM, Holbrook JT, Wei CY, Gerald LB, Teague WG, Wise RA, et al. Validation and psychometric properties of the Asthma Control Questionnaire among children. J Allergy Clin Immunol 2014;133: 91–97, e1–6.
43. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006;117:549–556.
44. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al.; American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59–99.
45. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107–1136.
46. Severien C, Artlich A, Jonas S, Becher G. Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma. Eur Respir J 2000;16:588–592.
47. Mai XM, Böttcher MF, Bruhammar M, Nilsson L, Zetterström O. Urinary inflammatory mediators and inhalation of hypertonic saline in children. Allergy 2005;60:60–64.
48. Slifkin M, Cumbie R. Comparison of the Histopaque-1119 method with the Plasmagel method for separation of blood leukocytes for cytomegalovirus isolation. J Clin Microbiol 1992;30:2722–2724.
49. Böyum A. Separation of leukocytes from blood and bone marrow: introduction. Scand J Clin Lab Invest Suppl 1968;97:7.
50. English D, Andersen BR. Single-step separation of red blood cells: granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods 1974;5:249–252.
51. Guijas C, Pérez-Chacón G, Astudillo AM, Rubio JM, Gil-de-Gómez L, Balboa MA, et al. Simultaneous activation of p38 and JNK by arachidonic acid stimulates the cytosolic phospholipase A2-dependent synthesis of lipid droplets in human monocytes. J Lipid Res 2012;53:2343–2354.
52. Lima JJ, Zhang S, Grant A, Shao L, Tantisira KG, Allayee H, et al. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 2006;173: 379–385.
53. Tantisira KG, Drazen JM. Genetics and pharmacogenetics of the leukotriene pathway. J Allergy Clin Immunol 2009;124:422–427.
54. Mougey E, Lang JE, Allayee H, Teague WG, Dozor AJ, Wise RA, et al. ALOX5 polymorphism associates with increased leukotriene production and reduced lung function and asthma control in children with poorly controlled asthma. Clin Exp Allergy 2013;43:512–520.
55. Telleria JJ, Blanco-Quiros A, Varillas D, Armentia A, Fernandez-Carvajal I, Jesus Alonso M, et al. ALOX5 promoter genotype and response to montelukast in moderate persistent asthma. Respir Med 2008;102: 857–861.
56. Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans 2017;45:1105–1115.
57. Kumar A, Mastana SS, Lindley MR. n-3 Fatty acids and asthma. Nutr Res Rev 2016;29:1–16.
58. Tremblay BL, Cormier H, Rudkowska I, Lemieux S, Couture P, Vohl MC. Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trial. Lipids Health Dis 2015;14:12.
59. Mickleborough TD, Lindley MR. Omega-3 fatty acids: a potential future treatment for asthma? Expert Rev Respir Med 2013;7:577–580.